AGENUS INC (25) | Intellectual Property (4)
Browse by Subcategory
Recent Contracts
-
License, Development and Commercialization Agreement, dated May 17, 2021, by and between Agenus Inc. and Bristol Myers Squibb Company
(Filed With SEC on August 9, 2021)
-
License Agreement dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc
(Filed With SEC on March 18, 2019)
-
Option and License Agreement (AGEN1223) dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc
(Filed With SEC on March 18, 2019)
-
Option and License Agreement (AGEN2373) dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc
(Filed With SEC on March 18, 2019)